Perceptive Xontogeny Venture Fund, LP
Insider CIK 1757940 · CATB Director, 10% owner · SLDB Director, 10% owner · LABP Director, 10% owner · LIAN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences Inc. | P Buy | 2025-02-19 | 2025-02-21 | 5,000,000 | $4.03 | $20.15M | 11,833,539 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2024-02-01 | 2024-02-05 | 2,481,350 | $12.09 | $30.00M | 4,873,721 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2024-01-11 | 2024-01-12 | 3,410,713 | $5.53 | $18.86M | 6,833,539 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-12-21 | 2023-12-22 | 740,000 | $6.20 | $4.59M | 2,392,371 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 460,546 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 1,151,366 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 921,093 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 345,409 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 1,611,699 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 1,652,371 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy deriv | 2023-01-10 | 2023-01-11 | 3,636,363 | $0.54 | $1.96M | 3,636,363 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy deriv | 2023-01-10 | 2023-01-11 | 27,272,727 | $0.54 | $14.73M | 27,272,727 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2022-12-19 | 2022-12-21 | 908,265 | $11.01 | $10.00M | 1,038,309 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 73,107 | — | $0 | 73,107 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 2,163,120 | $7.05 | $15.25M | 3,057,290 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 365,536 | — | $0 | 3,422,826 | SEC↗ |
| LIAN LianBio | P Buy | 2022-08-18 | 2022-08-22 | 998,240 | $2.40 | $2.40M | 3,728,491 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-26 | 2022-05-27 | 69,000 | $3.13 | $216.0K | 2,730,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-25 | 2022-05-25 | 120,000 | $2.63 | $315.6K | 2,661,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-24 | 2022-05-25 | 42,551 | $2.47 | $105.1K | 2,541,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-23 | 2022-05-25 | 8,700 | $2.49 | $21.7K | 2,498,700 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 635,369 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 423,579 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 2,477,005 | — | $0 | 2,477,005 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 3,715,510 | — | $0 | 10,969,395 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 14,619,500 | — | $0 | 25,588,895 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 14,619,500 | — | $0 | 21,653,385 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 2,923,000 | — | $0 | 4,330,675 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-03 | 2021-11-05 | 20,000 | $13.51 | $270.2K | 27,858,895 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-03 | 2021-11-05 | 2,250,000 | $16.00 | $36.00M | 27,838,895 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-02 | 2021-11-03 | 100,000 | $13.50 | $1.35M | 7,253,885 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-01 | 2021-11-03 | 120,000 | $15.50 | $1.86M | 7,153,885 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2021-08-27 | 2021-08-31 | 25,291 | — | $0 | 25,291 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 34,951 | $14.60 | $510.3K | 7,299,751 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 64,730 | $13.80 | $893.3K | 7,264,800 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 1,770,600 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-08 | 1,250,000 | $16.00 | $20.00M | 7,049,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 1,771 | $13.10 | $23.2K | 7,200,070 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 86,671 | $12.53 | $1.09M | 7,198,299 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 34,611 | $11.38 | $393.9K | 7,111,628 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-05 | 2021-02-09 | 27,453 | $11.14 | $305.8K | 7,077,017 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-02-01 | 2021-02-03 | 4,851 | $3009.53 | $14.60M | 4,851 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-02-01 | 2021-02-03 | 1,617 | $3009.53 | $4.87M | 30,920 | SEC↗ |